Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04257110
Title A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bliss Biopharmaceutical (Hangzhou) Co., Ltd

breast cancer

Advanced Solid Tumor

stomach cancer

gastroesophageal cancer



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.